|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.36B 105B 1.19B 1.1B 1.02B 1.93B 129B 1.97B 13.18B 5.11B 63.28B 5.09B 4.98B 220B | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 163B 1.84B 1.69B 1.58B 2.97B 199B 3.03B 20.34B 7.88B 97.64B 7.86B 7.69B 340B | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 31/12/2013 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Gorelik
BRD | Director/Board Member | 47 | 31/12/2006 |
| Director/Board Member | 46 | 31/12/2012 | |
Dmitriy Genkin
CHM | Chairman | 57 | 31/12/2004 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 25.27M | |
| -0.64% | +6.67% | +53.59% | +154.11% | 1,070B | |
| +0.00% | +5.39% | +62.89% | +53.44% | 611B | |
| -0.23% | +6.88% | +32.14% | +86.34% | 445B | |
| -1.20% | -0.96% | +26.12% | +20.22% | 329B | |
| -1.74% | -0.40% | +33.19% | +22.86% | 290B | |
| -1.25% | +0.53% | +27.68% | +38.89% | 287B | |
| +2.99% | +4.00% | -26.09% | -41.06% | 213B | |
| -0.22% | +2.82% | +24.37% | +62.75% | 195B | |
| -0.29% | +0.65% | +12.75% | +63.45% | 157B | |
| Average | +0.76% | +3.58% | +24.67% | +46.10% | 359.63B | |
| Weighted average by Cap. | -0.42% | +4.20% | +38.21% | +76.13% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 438M 34.08B 385M 354M 330M 623M 41.67B 635M 4.26B 1.65B 20.46B 1.65B 1.61B 71.19B | 380M 29.52B 333M 307M 286M 539M 36.1B 550M 3.69B 1.43B 17.72B 1.43B 1.39B 61.66B |
| Net income | -698M -54.23B -612M -564M -525M -991M -66.32B -1.01B -6.78B -2.63B -32.55B -2.62B -2.56B -113B | -207M -16.13B -182M -168M -156M -295M -19.73B -301M -2.02B -781M -9.68B -779M -762M -33.7B |
| Net Debt | 693M 53.87B 608M 560M 522M 984M 65.88B 1B 6.74B 2.61B 32.34B 2.6B 2.55B 113B | 736M 57.24B 646M 595M 554M 1.05B 70B 1.07B 7.16B 2.77B 34.36B 2.76B 2.7B 120B |
Employees
60
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
